(Q34336956)

1 August 2017

1 reference

title

Estrogens and cell-cycle regulation in breast cancer (English)

1 reference

1 August 2017

1 reference

1 reference

Foster JS

1

1 reference

1 August 2017

Henley DC

series ordinal

2

1 reference

1 August 2017

Ahamed S

series ordinal

3

1 reference

1 August 2017

Wimalasena J

series ordinal

4

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Trends in Endocrinology and Metabolism

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

320-327

1 reference

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Control of cell proliferation by Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

p27kip1-independent cell cycle regulation by MYC.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Mysterious liaisons: the relationship between c-Myc and the cell cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Myc-mediated transformation: the repression connection

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen Induces Early and Timed Activation of Cyclin-Dependent Kinases 4, 5, and 6 and Increases Cyclin Messenger Ribonucleic Acid Expression in Rat Uterus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen receptor pathways to AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Evolving ideas about cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

G1-S transition defects occur in most breast cancers and predict outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cdc25 cell-cycle phosphatase as a target of c-myc

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Role of the Cdc25A phosphatase in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Pathways governing G1/S transition and their response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

Cellular Functions of the Plasma Membrane Estrogen Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900436-2

7 January 2021

10.1016/S1043-2760(01)00436-2

Identifiers

DOI

1 reference

1 August 2017

1 reference